Natural History (up to 15 years) of Platelet Count in 84 Patients with Familial Hyperchylomicronemia Due to Lipoprotein Lipase Deficiency
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A natural history study of 87 familial chylomicronemia syndrome patients over 15 years found marked platelet count variability: 55.2% had thrombocytopenia at least once, 2.4% had counts below 50,000 per microliter, and 12.6% had thrombocytosis.
“A recently reported natural history study of 87 patients with familial chylomicronemia syndrome over a 15-year period indicates considerable lability in platelet counts: 55.2% had thrombocytopenia on at least one occasion, and 2.4% had platelet levels of less than 50,000 per microliter, whereas 12.6% presented with thrombocytosis.35”
From Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome (2019) · cites this paper as [35]
Cites
Still being checked.
Cited by
Sorted by citations
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
Witztum, J. L., Gaudet, D., Freedman, S. D., Alexander, V. J., Digenio, A., Williams, K. R., Yang, Q., Hughes, S. G., Geary, R. S., Arca, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1715944 · Cited by 669 · see citing works
Self-citationAlexander, V. J., Xia, S., Hurh, E., Hughes, S. G., O’Dea, L., Geary, R. S., Witztum, J. L., & Tsimikas, S. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz209 · Cited by 231 · see citing works
Tardif, J.-C., Karwatowska-Prokopczuk, E., Amour, E. S., Ballantyne, C. M., Shapiro, M. D., Moriarty, P. M., Baum, S. J., Hurh, E., Bartlett, V. J., Kingsbury, J., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab820 · Cited by 210 · see citing works
Self-citationGenetic Determinants of Lipids and Cardiovascular Disease Outcomes
Allara, E., Morani, G., Carter, P., Gkatzionis, A., Zuber, V., Foley, C. N., Rees, J. M. B., Mason, A. M., Bell, S., Gill, D., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002711 · Cited by 141 · see citing works
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias
Katzmann, J. L., Packard, C. J., Chapman, M. J., Katzmann, I., & Laufs, U. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.070 · Cited by 99 · see citing works
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
Packard, C. J., Pirillo, A., Tsimikas, S., Ference, B. A., & Catapano, A. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad177 · Cited by 65 · see citing works
Hypertriglyceridemia: new approaches in management and treatment
Wolska, A. T., Yang, Z., & Remaley, A. T. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000710 · Cited by 50 · see citing works
Jones, A., Peers, K., Wierzbicki, A. S., Ramachandran, R., Mansfield, M., Dawson, C., Ochoa-Ferraro, A., Soran, H., Jenkinson, F., McDowell, I., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.05.008 · Cited by 39 · see citing works
APOC3 siRNA and ASO therapy for dyslipidemia
Chebli, J., Larouche, M., & Gaudet, D. (2024) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000857 · Cited by 35 · see citing works
Self-citationVolanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia
Khetarpal, S. A., Wang, M., & Khera, A. V. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1912350 · Cited by 33 · see citing works
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention
Makhmudova, U., Steinhagen‐Thiessen, E., Volpe, M., & Landmesser, U. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae136 · Cited by 30 · see citing works
Recent Apolipoprotein CIII trials
Tramontano, D., Bini, S., D’Erasmo, L., & Arca, M. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000849 · Cited by 14 · see citing works
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?
Biolo, M., Galimberti, F., Portinari, C., Bertocco, S., Tosin, P., Casula, M., Previato, L., Zambon, S., Simioni, P., & Zambon, A. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01315-w · Cited by 9 · see citing works
Chylomicronemia through a burr hole: A case report
Loh, W. J., Bakthavachalam, R., Subramaniam, T., Pek, S. L. T., Chua, F., Lee, L., & Watts, G. F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1020397 · Cited by 5 · see citing works
Larouche, M., Brisson, D., Morissette, M.-C., & Gaudet, D. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02743-0 · Cited by 4 · see citing works
Self-citationCalcaterra, I. L., Santoro, R., Vitelli, N., Cirillo, F., D’Errico, G., Guerrino, C., Cardiero, G., Taranto, M. D. D., Fortunato, G., Iannuzzo, G., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092017 · Cited by 3 · see citing works
Valéro, R. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.06.013 · Cited by 2 · see citing works
Hooper, A. J., Bell, D. A., & Burnett, J. R. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2437524
Alexander, V. J., Prohaska, T. A., Karwatowska‐Prokopczuk, E., Xia, S., & Tsimikas, S. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.05.007
- Authors
- Gaudet, D., Baass, A., Tremblay, K., Brisson, D., Laflamme, N., Paquette, M., Dufour, R., & Bergeron, J.
- ORCID
- Venue
- Journal of Clinical Lipidology
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 11
- Issue
- 3
- Pages
- 797-798
- ISSN
- 1876-4789 (ISSN-L)
- 1933-2874
- OpenAlex
- W2612430640
- Cited by
- 19
- References
- 0
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 4
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of clinical lipidology (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- lipoprotein lipase deficiency, platelet count, hypertriglyceridemia, natural history (disease)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
